{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:34:03Z","timestamp":1790868843222,"version":"4.1.0"},"reference-count":34,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Background: Rift Valley fever virus (RVFV) is a significant mosquito-borne zoonotic virus with high public health and veterinary importance in Africa and the Middle East. Reliable diagnostic assays for detecting antibodies and assessing their functional neutralizing capacity are essential for surveillance programs, vaccine monitoring, and outbreak preparedness. Objective: This study evaluates and compares the analytical performance of a competitive enzyme-linked immunosorbent assay (cELISA) and a virus neutralization test (VNT) for detecting RVFV antibodies in vaccinated sheep sera, establishing an integrated laboratory workflow for virus titration, serological detection, and functional neutralization. Methods: Twenty serum samples were collected from sheep pre-vaccination and one month post-vaccination with Smithburn live attenuated RVFV vaccine. Sera were tested using a commercial multispecies RVFV competitive ELISA to detect antibodies specific to the viral nucleocapsid protein. Viral titration was conducted in Vero cells, and 50% tissue culture infective dose (TCID50\/0.1 mL) was calculated using the Reed and Muench method. VNT was performed at 24, 48, 72, and 96 h after infection with different viral doses (102 to 105\u00a0TCID50\/0.1 mL), and the neutralizing ability of serial serum dilutions (1:2 to 1:1024) was tested. Compared with the control, protection was determined by cytopathic effect (CPE) inhibition. Results: ELISA revealed robust antibody signals up to a 1:32 dilution, with signal-to-noise (S\/N) &lt; 40%, whereas for higher dilutions, antibody detection became inconclusive or negative. Virus titration was performed to verify a stock concentration of 106.5\u00a0TCID50\/0.1 mL. The VNT exhibited time- and dose-dependent kinetics; high protection rates (\u226597) were observed at 1:2\u20131:8 dilutions against 102\u2013103\u00a0TCID50\/0.1 mL challenge doses; however, neutralizing efficacy decreased significantly at higher viral loads and higher serum dilutions. While cELISA and VNT results correlated strongly at low serum dilutions, the cELISA showed decreased sensitivity at dilutions \u2265 1:64, where the VNT remained capable of detecting functional neutralizing activity. Conclusions\/Discussion: The results demonstrate that while both assays correlate well at high antibody concentrations, they diverge at lower concentrations. This discrepancy highlights the functional difference between binding antibodies (N-protein) and neutralizing antibodies (Gn\/Gc glycoproteins). Consequently, the cELISA is ideal for rapid screening, whereas the VNT is indispensable for confirming functional immunity. Integrating both assays provides a more accurate immunological profile for RVFV surveillance and vaccine evaluation.<\/jats:p>","DOI":"10.3390\/pathogens15030264","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:06:56Z","timestamp":1772460416000},"page":"264","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrated Laboratory Evaluation of Rift Valley Fever Virus Antibodies Using the Competitive ELISA and Virus Neutralization Test"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8159-4813","authenticated-orcid":false,"given":"Ommer M.","family":"Dafalla","sequence":"first","affiliation":[{"name":"The National Center for the Prevention & Control of Plant Pests & Animal Diseases (Weqaa), Operation Sector, General Department of Laboratories\u2014Jazan Laboratory, Jizan 82224 , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah A.","family":"Alashor","sequence":"additional","affiliation":[{"name":"The National Center for the Prevention & Control of Plant Pests & Animal Diseases (Weqaa), Operation Sector, General Department of Laboratories\u2014Jazan Laboratory, Jizan 82224 , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6661-2988","authenticated-orcid":false,"given":"Mohammed O.","family":"Hussien","sequence":"additional","affiliation":[{"name":"The National Center for the Prevention & Control of Plant Pests & Animal Diseases (Weqaa), Operation Sector, General Department of Laboratories\u2014Jazan Laboratory, Jizan 82224 , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsiddig M.","family":"Noureldin","sequence":"additional","affiliation":[{"name":"The National Center for the Prevention & Control of Plant Pests & Animal Diseases (Weqaa), Operation Sector, General Department of Laboratories\u2014Jazan Laboratory, Jizan 82224 , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2099-2815","authenticated-orcid":false,"given":"Tellal B.","family":"Ageep","sequence":"additional","affiliation":[{"name":"The National Center for the Prevention & Control of Plant Pests & Animal Diseases (Weqaa), Operation Sector, General Department of Laboratories\u2014Jazan Laboratory, Jizan 82224 , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Najmi","sequence":"additional","affiliation":[{"name":"The National Center for the Prevention & Control of Plant Pests & Animal Diseases (Weqaa), Operation Sector, General Department of Laboratories\u2014Jazan Laboratory, Jizan 82224 , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Mohamed","sequence":"additional","affiliation":[{"name":"The National Center for the Prevention & Control of Plant Pests & Animal Diseases (Weqaa), Operation Sector, General Department of Laboratories\u2014Jazan Laboratory, Jizan 82224 , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali A.","family":"Hakami","sequence":"additional","affiliation":[{"name":"The National Center for the Prevention & Control of Plant Pests & Animal Diseases (Weqaa), Operation Sector, General Department of Laboratories\u2014Jazan Laboratory, Jizan 82224 , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh A.","family":"Alrashedi","sequence":"additional","affiliation":[{"name":"The National Center for the Prevention & Control of Plant Pests & Animal Diseases (Weqaa), Operation Sector, General Department of Laboratories, Riyadh, 11461, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fisal A.","family":"Bushlaibi","sequence":"additional","affiliation":[{"name":"The National Center for the Prevention & Control of Plant Pests & Animal Diseases (Weqaa), Operation Sector, General Department of Laboratories, Riyadh, 11461, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad N.","family":"Abukhalil","sequence":"additional","affiliation":[{"name":"The National Center for the Prevention & Control of Plant Pests & Animal Diseases (Weqaa), Operation Sector, General Department of Laboratories, Riyadh, 11461, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1128\/JVI.75.3.1371-1377.2001","article-title":"Genetic evidence for an Interferon-Antagonistic function of Rift Valley Fever Virus Nonstructural Protein NSS","volume":"75","author":"Bouloy","year":"2001","journal-title":"J. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.medmal.2010.12.010","article-title":"Fi\u00e8vre de la vall\u00e9e du Rift","volume":"41","year":"2011","journal-title":"M\u00e9decine Mal. Infect."},{"key":"ref_3","unstructured":"European Centre for Disease Prevention and Control (2019, March 07). RAPID RISK ASSESSMENT, Rift Valley Fever Outbreak in Mayotte, France, Available online: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/RRA-Rift-Valley-fever-Mayotte-France-March-2019.pdf."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2007.01.046","article-title":"Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease","volume":"362","author":"Bird","year":"2007","journal-title":"Virology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1016\/j.vaccine.2017.04.024","article-title":"Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy","volume":"35","author":"Schreur","year":"2017","journal-title":"Vaccine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-1-0716-0346-8_23","article-title":"Serum virus neutralization assay for detection and quantitation of serum neutralizing antibodies to influenza A virus in swine","volume":"2123","author":"Gauger","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/jmv.25986","article-title":"Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples","volume":"92","author":"Manenti","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1099\/jgv.0.001481","article-title":"SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients","volume":"101","author":"Klimstra","year":"2020","journal-title":"J. Gen. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jviromet.2005.02.008","article-title":"An inhibition enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in humans, domestic and wild ruminants","volume":"127","author":"Paweska","year":"2005","journal-title":"J. Virol. Methods"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0019-2791(71)90454-X","article-title":"Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin G","volume":"8","author":"Engvall","year":"1971","journal-title":"Immunochemistry"},{"key":"ref_12","first-page":"e52065","article-title":"Viral concentration determination through plaque assays: Using traditional and novel overlay systems","volume":"93","author":"Baer","year":"2014","journal-title":"J. Vis. Exp."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"100040","DOI":"10.1016\/j.xcrm.2020.100040","article-title":"Rapid generation of neutralizing antibody responses in COVID-19 patients","volume":"1","author":"Suthar","year":"2020","journal-title":"Cell Rep. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1038\/s41467-020-17892-0","article-title":"A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation","volume":"11","author":"Muruato","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jviromet.2012.03.008","article-title":"Bead-based suspension array for simultaneous detection of antibodies against the Rift Valley fever virus nucleocapsid and Gn glycoprotein","volume":"183","author":"Achterberg","year":"2012","journal-title":"J. Virol. Methods"},{"key":"ref_16","unstructured":"BioIVT: Trusted Biospecimen & Services Provider (2023, February 14). Cell Counting Using the Trypan Blue Exclusion Method [Video]. YouTube. Available online: https:\/\/www.youtube.com\/watch?v=qVs2Pczcruo."},{"key":"ref_17","unstructured":"(2025, June 10). Ppr-Labs-Oie-Network.Org. Standard Operating Procedures\/Materials and Protocols\u2014OIE Reference Laboratory Network for Peste des Petits Ruminants (PPR). Available online: https:\/\/www.ppr-labs-oie-network.org\/en\/materials-and-protocols\/standard-operating-procedures."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/tropej\/fmn001","article-title":"Virology: Principles and applications","volume":"55","author":"Ebrahim","year":"2007","journal-title":"J. Trop. Pediatr."},{"key":"ref_19","unstructured":"(2011, January 01). Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza. Available online: https:\/\/www.who.int\/publications\/i\/item\/manual-for-the-laboratory-diagnosis-and-virological-surveillance-of-influenza."},{"key":"ref_20","unstructured":"Schmidt, N.J., and Emmons, R.W. (1989). Arboviruses. Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections, American Public Health Association. [6th ed.]."},{"key":"ref_21","unstructured":"Lennette, E.H., Lennette, D.A., and Lennette, E.T. (1995). Arboviruses. Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections, American Public Health Association. [7th ed.]."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1515\/cclm-2020-0443","article-title":"Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM\/IgG and antibody kinetics","volume":"58","author":"Padoan","year":"2020","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1056\/NEJMsr2105280","article-title":"SARS-CoV-2 variants and vaccines","volume":"385","author":"Krause","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nat. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.chom.2020.06.021","article-title":"Neutralizing antibody and soluble ACE2 inhibition of a Replication-Competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2","volume":"28","author":"Case","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jviromet.2007.06.006","article-title":"Validation of an indirect ELISA based on a recombinant nucleocapsid protein of Rift Valley fever virus for the detection of IgG antibody in humans","volume":"146","author":"Paweska","year":"2007","journal-title":"J. Virol. Methods"},{"key":"ref_28","first-page":"87","article-title":"Mechanisms of virus neutralization by antibody","volume":"260","author":"Klasse","year":"2001","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_29","unstructured":"Innovative Diagnostics (2026, January 15). ID Screen\u00ae Rift Valley Fever Competition Multispecies. Available online: https:\/\/www.innovative-diagnostics.com\/produit\/id-screen-rift-valley-fever-competition-multi-species\/."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/vbz.2015.1855","article-title":"Crimean-Congo Hemorrhagic fever virus subunit vaccines induce high levels of neutralizing antibodies but no protection in STAT1 knockout mice","volume":"15","author":"Kortekaas","year":"2015","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"ref_31","unstructured":"World Health Organization Department of Communicable Disease Surveillance and Response WHO Global Influenza Programme (2025, June 10). WHO Animal Influenza Manual. WHO Manual on Animal Influenza Diagnosis and Surveillance. Available online: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/2c04b1a7-27e4-44ab-9a88-3db0ff51bbb1\/content."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1177\/24725552211039754","article-title":"Treating cells as reagents to design reproducible assays","volume":"26","author":"Riss","year":"2021","journal-title":"SLAS Discov."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1017\/S1462399408000665","article-title":"Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection","volume":"10","author":"Pierson","year":"2008","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_34","first-page":"128","article-title":"Comparison of assays for the detection of West Nile virus antibodies in chicken serum","volume":"67","author":"Weingartl","year":"2003","journal-title":"Can. J. Vet. Res."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/3\/264\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:27:16Z","timestamp":1772461636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/3\/264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["pathogens15030264"],"URL":"https:\/\/doi.org\/10.3390\/pathogens15030264","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]}}}